NERIDRONATE SODIUM HYDRATE
| Price | $1 |
| Package | 1KG |
| Min. Order: | 1KG |
| Supply Ability: | 1ton |
| Update Time: | 2020-01-05 |
Product Details
| Product Name: NERIDRONATE SODIUM HYDRATE | CAS No.: 79778-41-9 |
| EC-No.: 200-258-5 | Min. Order: 1KG |
| Purity: 95--99% | Supply Ability: 1ton |
| Release date: 2020/01/05 | |
| contact: flora@coreychem.com |
▼
▲
NERIDRONATE SODIUM HYDRATE Basic information
▼
▲
Product Name:
NERIDRONATE SODIUM HYDRATE
Synonyms:
6-amino-1-hydroxyhexane-1,1-diphosphonate;Neridronic;6-Amino-1-hydroxyhexylidene bisphosphonic acid, Neridronic acid, Nerixia;(6-AMino-1-hydroxyhexane-1,1-diyl)diphosphonic acid;Phosphonic acid,P,P'-(6-aMino-1-hydroxyhexylidene)bis-;6-amino-1-hydroxyhexane-1,1-diphosphonic acid;6-AMINO-1-HYDROXYHEXYLIDENE BISPHOSPHONIC ACID;NERIXIA
CAS:
79778-41-9
MF:
C6H17NO7P2
MW:
277.15
EINECS:
Product Categories:
Mol File:
79778-41-9.mol
▼
▲
NERIDRONATE SODIUM HYDRATE Chemical Properties
▼
▲
Melting point
245°
Boiling point
600.1±65.0 °C(Predicted)
density
1.658±0.06 g/cm3(Predicted)
storage temp.
2-8°C
solubility
H2O: 8 mg/mL, soluble
pka
1.93±0.10(Predicted)
form
solid
color
white
▼
▲
Safety Information
▼
▲
Hazard Codes
Xn
Risk Statements
22
WGK Germany
3
▼
▲
MSDS Information
▼
▲
Provider
Language
SigmaAldrich
English
▼
▲
NERIDRONATE SODIUM HYDRATE Usage And Synthesis
▼
▲
Description
Neridronic acid was launched in Italy as intravenous or intramuscular injection for the treatment of osteogenesis imperfecta. It is the first drug launched worldwide for this “orphan disease” characterized by a fragility of the bone. Sufferers risk frequent fractures commencing during infancy, eventually leading to bone deformation and a severe deterioration of the quality of life and life expectancy. Neridronic acid is structurally related to the second generation of bisphosphonates characterized by an amino terminal group and can be synthesized by treating E-aminocaproic acid with phosphoric acid and phosphorous trichloride. Bisphosphonates, synthetic analogs of the endogenous mineral deposition inhibitor pyrophosphate, are extremely potent inhibitors of bone resorption and increase bone mineral density, possibly by inhibiting the activity of osteoclasts and promoting the death of these bone-eroding cells. In vitro, neridronic acid was a poor inhibitor of phagocytosis, but significantly and dose dependently inhibited 8glucuronidase release and superoxide anion production in the rat peritoneal macrophage, two parameters that may have a part in bone resorption. In a clinical study on patients with osteogenesis imperfecta, neridronic acid increased remarkably bone mass in young growing individuals. In adults the changes were less important but still significant.
Originator
lnstituto Gentili (Italy)
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00/1KG |
VIP5Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-01-16 | |
| $1.00/1g |
VIP1Y
|
Apeloa production Co.,Limited
|
2024-06-05 | |
| $1.50/1kg |
VIP2Y
|
Hebei Duling International Trade Co. LTD
|
2024-05-30 | |
| $550.00/25g |
VIP1Y
|
R&D Scientific Inc.
|
2024-05-07 |
China- Since: 2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY